OpenLB
Open Library of Bioscience
Advanced Search
Obesity (Silver Spring, Md.)
08, 2024;32 (8): 1494-1507.

Comparing the metabolic signatures of obesity defined by waist circumference, waist-hip ratio, or BMI.

Moustafa Al Hariri, Haya Al-Sulaiti, Najeha Anwardeen, Khaled Naja, Mohamed A Elrayess
Author Information
  1. Moustafa Al Hariri: College of Medicine, QU Health Sector, Qatar University, Doha, Qatar. ORCID
  2. Haya Al-Sulaiti: Department of Biomedical Sciences, College of Health Sciences, QU Health Sector, Qatar University, Doha, Qatar.
  3. Najeha Anwardeen: Biomedical Research Center, Qatar University, Doha, Qatar.
  4. Khaled Naja: Biomedical Research Center, Qatar University, Doha, Qatar.
  5. Mohamed A Elrayess: College of Medicine, QU Health Sector, Qatar University, Doha, Qatar.
PMID: 38967317 DOI: 10.1002/oby.24070

Abstract

OBJECTIVE: Measuring obesity is crucial for assessing health risks and developing effective prevention and treatment strategies. The most common methods used to measure obesity include BMI, waist circumference, and waist-hip ratio. This study aimed to determine the metabolic signatures associated with each measure of obesity in the Qatari population.
METHODS: Metabolomics profiling was conducted to identify, quantify, and characterize metabolites in serum samples from the study participants. Inverse rank normalization, principal component analysis, and orthogonal partial least square-discriminant analysis were used to analyze the metabolomics data.
RESULTS: This study revealed significant differences in metabolites associated with obesity based on different measurements. In men, phosphatidylcholine and phosphatidylethanolamine metabolites were significantly enriched in individuals classified as having obesity based on the waist-hip ratio. In women, significant changes were observed in leucine, isoleucine, and valine metabolism metabolites. Unique metabolites were found in the different categorization groups that could serve as biomarkers for assessing many obesity-related disorders.
CONCLUSIONS: This study identified unique metabolic signatures associated with obesity based on different measurements in the Qatari population. These findings contribute to a better understanding of the molecular pathways involved in obesity and may have implications for developing personalized prevention and treatment strategies.

References

Panuganti KK, Nguyen M, Kshirsagar RK. Obesity. In: StatPearls. StatPearls Publishing; 2023.
Bener A, Yousafzai MT, Darwish S, Al‐Hamaq AOAA, Nasralla EA, Abdul‐Ghani M. Obesity index that better predict metabolic syndrome: body mass index, waist circumference, waist hip ratio, or waist height ratio. J Obes. 2013;2013:269038.
Nuttall FQ. Body mass index: Obesity, BMI, and health: a critical review. Nutr Today. 2015;50(3):117‐128.
Andreacchi AT, Griffith LE, Guindon GE, et al. Body mass index, waist circumference, waist‐to‐hip ratio, and body fat in relation to health care use in the Canadian longitudinal study on aging. Int J Obes (Lond). 2021;45(3):666‐676.
Veghari G, Salehi A, Vaghari M. The comparison of waist circumference, waist‐to‐hip ratio, and waist‐to‐height ratio among rural women adults in the North of Iran, between the years 2004 and 2013. ARYA Atheroscler. 2018;14(4):169‐176.
Lean MEJ, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ. 1995;311(6998):158‐161.
Li Y, He Y, Yang L, et al. Body roundness index and waist‐hip ratio result in better cardiovascular disease risk stratification: results from a large Chinese cross‐sectional study. Front Nutr. 2022;9:801582.
Bojanic D, Ljubojevic M, Krivokapic D, Gontarev S. Waist circumference, waist‐to‐hip ratio, and waist‐to‐height ratio reference percentiles for abdominal obesity among Macedonian adolescents. Nutr Hosp. 2020;37(4):786‐793.
World Health Organization. Waist circumference and waist‐hip ratio: report of a WHO expert consultation. WHO; 2011.
Cheng D, Zhao X, Yang S, Cui H, Wang G. Metabolomic signature between metabolically healthy overweight/obese and metabolically unhealthy overweight/obese: a systematic review. Diabetes Metab Syndr Obes. 2021;14:991‐1010.
Rinschen MM, Ivanisevic J, Giera M, Siuzdak G. Identification of bioactive metabolites using activity metabolomics. Nat Rev Mol Cell Biol. 2019;20(6):353‐367.
Vega GL, Adams‐Huet B, Peshock R, Willett DW, Shah B, Grundy SM. Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab. 2006;91(11):4459‐4466.
Zazai R, Wilms B, Ernst B, Thurnheer M, Schultes B. Waist circumference and related anthropometric indices are associated with metabolic traits in severely obese subjects. Obes Surg. 2014;24:777‐782.
Abu Bakar MH, Sarmidi MR, Cheng KK, et al. Metabolomics – the complementary field in systems biology: a review on obesity and type 2 diabetes. Mol BioSyst. 2015;11(7):1742‐1774.
Al‐Sulaiti H, Diboun I, Agha MV, et al. Metabolic signature of obesity‐associated insulin resistance and type 2 diabetes. J Transl Med. 2019;17(1):348.
Al‐Khelaifi F, Diboun I, Donati F, et al. A pilot study comparing the metabolic profiles of elite‐level athletes from different sporting disciplines. Sports Med Open. 2018;4(1):2.
DeHaven CD, Evans AM, Dai H, Lawton KA. Software techniques for enabling high‐throughput analysis of metabolomic datasets. Metabolomics. 2012;10:167‐192.
Wishart DS, Guo AC, Oler E, et al. HMDB 5.0: the human metabolome database for 2022. Nucleic Acids Res. 2022;50(D1):D622‐d631.
Bonithon‐Kopp C, Raison J, Egloff M, Guy‐Grand B, Ducimetière P. Skinfold and body circumferences as measures of body fat patterning in a French female active population: relationships with the metabolic risk profile. J Clin Epidemiol. 1991;44(6):475‐482.
Björntorp P. Abdominal fat distribution and the metabolic syndrome. J Cardiovasc Pharmacol. 1992;20(suppl 8):S26‐S28.
Wannamethee SG, Shaper AG, Morris RW, Whincup PH. Measures of adiposity in the identification of metabolic abnormalities in elderly men 2, 3. Am J Clin Nutr. 2005;81(6):1313‐1321.
Park S, Sadanala KC, Kim EK. A metabolomic approach to understanding the metabolic link between obesity and diabetes. Mol Cells. 2015;38(7):587‐596.
Lind L, Sundström J, Elmståhl S, et al. The metabolomic profile associated with clustering of cardiovascular risk factors‐a multi‐sample evaluation. PLoS One. 2022;17(9):e0274701.
Parnell L, Noel SE, Bhupathiraju SN, et al. Metabolite patterns link diet, obesity, and type 2 diabetes in a Hispanic population. Metabolomics. 2021;17:88.
Kliemann N, Viallon V, Murphy N, et al. Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European prospective investigation into cancer and nutrition. BMC Med. 2021;19(1):101.
Raja G, Gupta H, Gebru YA, et al. Recent advances of microbiome‐associated metabolomics profiling in liver disease: principles, mechanisms, and applications. Int J Mol Sci. 2021;22(3):1160.
Dubin RF, Rhee EP. Proteomics and metabolomics in kidney disease, including insights into etiology, treatment, and prevention. Clin J Am Soc Nephrol. 2020;15(3):404‐411.
Liu BN, Liu XT, Liang ZH, Wang JH. Gut microbiota in obesity. World J Gastroenterol. 2021;27(25):3837‐3850.
Gomes AC, Hoffmann C, Mota JF. The human gut microbiota: metabolism and perspective in obesity. Gut Microbes. 2018;9(4):308‐325.
Gill VJS, Soni S, Shringarpure M, et al. Gut microbiota interventions for the management of obesity: a literature review. Cureus. 2022;14(9):e29317.
Ryan E, Joyce SA, Clarke DJ. Membrane lipids from gut microbiome‐associated bacteria as structural and signalling molecules. Microbiology (Reading). 2023;169(3):mic.0.001315.
Mawatari S, Sasuga Y, Morisaki T, Okubo M, Emura T, Fujino T. Identification of plasmalogens in Bifidobacterium longum, but not in Bifidobacterium animalis. Sci Rep. 2020;10(1):427.
Jackson DR, Cassilly CD, Plichta DR, et al. Plasmalogen biosynthesis by anaerobic bacteria: identification of a two‐gene operon responsible for plasmalogen production in Clostridium perfringens. ACS Chem Biol. 2021;16(1):6‐13.
Ryan E, Gonzalez Pastor B, Gethings LA, Clarke DJ, Joyce SA. Lipidomic analysis reveals differences in Bacteroides species driven largely by plasmalogens, glycerophosphoinositols and certain sphingolipids. Metabolites. 2023;13(3):360.
Liu Y, Jiao C, Zhang T, et al. Early‐life gut microbiota governs susceptibility to colitis via microbial‐derived ether lipids. Research (Wash D C). 2023;6:37.
Rafique N, Jan SY, Dar AH, et al. Promising bioactivities of postbiotics: a comprehensive review. J Agric Food Res. 2023;14:100708.
Kindt A, Liebisch G, Clavel T, et al. The gut microbiota promotes hepatic fatty acid desaturation and elongation in mice. Nat Commun. 2018;9(1):3760.
Mitchell MK, Ellermann M. Long chain fatty acids and virulence repression in intestinal bacterial pathogens. Front Cell Infect Microbiol. 2022;12:928503.
Johnson E et al. Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels. Nat Commun. 2020;11:2471.
Menni C, Zhu J, le Roy CI, et al. Serum metabolites reflecting gut microbiome alpha diversity predict type 2 diabetes. Gut Microbes. 2020;11(6):1632‐1642.
Wilmanski T, Rappaport N, Earls JC, et al. Blood metabolome predicts gut microbiome alpha‐diversity in humans. Nat Biotechnol. 2019;37(10):1217‐1228.
Sheng S, Yan S, Chen J, et al. Gut microbiome is associated with metabolic syndrome accompanied by elevated gamma‐glutamyl transpeptidase in men. Front Cell Infect Microbiol. 2022;12:946757.

Grants

  1. PPM 06-0516-230030/Qatar National Research Fund

MeSH Term

Humans
Male
Female
Obesity
Waist Circumference
Body Mass Index
Adult
Waist-Hip Ratio
Middle Aged
Metabolomics
Biomarkers
Phosphatidylcholines
Leucine
Phosphatidylethanolamines
Isoleucine
Principal Component Analysis
Metabolome

Chemicals

Biomarkers
Phosphatidylcholines
Leucine
Phosphatidylethanolamines
Isoleucine
Journal Article Comparative Study Research Support, Non-U.S. Gov't

Word Cloud

Similar Articles

Cited By